NCT04078672View on ClinicalTrials.gov

Retinal Imaging Using NOTAL-OCT V3.0

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

December 2, 2019

Primary Completion Date

January 30, 2023

Study Completion Date

March 26, 2023

Conditions
AMDDR
Interventions
PROCEDURE

NOTAL-OCT V3.0

AMD and DR patients

Trial Locations (2)

Unknown

Assuta Hashalom, Tel Aviv

Tel Aviv Medical Center, Tel Aviv

Sponsors

Lead Sponsor

Notal Vision Ltd.
All Listed Sponsors
lead

Notal Vision Ltd.

INDUSTRY

NCT04078672 - Retinal Imaging Using NOTAL-OCT V3.0 | Biotech Hunter | Biotech Hunter